The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study
Open accessPublished version of a preprint
Abstract
On March 11, 2020, the World Health Organization declared its assessment of coronavirus disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) drugs are still under development, and patients are managed by multiple complementary treatments. We performed a retrospective analysis to compare and evaluate the effect of low molecular weight heparin (LMWH) treatment on disease progression. For this purpose, the clinical records and laboratory indicators were extracted from electronic medical records of 42 patients with COVID‐19 (21 of whom were treated with LMWH, and 21 without LMWH) hospitalized (Union Hospital of Huazhong University of Science and Technology) from February 1 to March 15, 2020. Changes in the percentage of lymphocytes before and after LMWH treatment were significantly different from those in the control group ( P = 0.011). Likewise, changes in the levels of D‐dimer and fibrinogen degradation products in the LMWH group before and after treatment were significantly different from those in the control group ( P = 0.035). Remarkably, IL‐6 levels were significantly reduced after LMWH treatment ( P = 0.006), indicating that, besides other beneficial properties, LMWH may exert an anti‐inflammatory effect and attenuate in part the “cytokine storm” induced by the virus. Our results support the use of LMWH as a potential therapeutic drug for the treatment of COVID‐19, paving the way for a subsequent well‐controlled clinical study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationSARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Pedersen, S. F., & Ho, Y.-C. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137647 · Cited by 1,137
Teachey, D. T., Lacey, S. F., Shaw, P. A., Melenhorst, J. J., Maude, S. L., Frey, N., Pequignot, E., Gonzalez, V. E., Chen, F., Finklestein, J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0040 · Cited by 1,102
Research works printed but not linked: 34
- 10.1016/S0140-6736(20)30185-9 · DOI · Paper page
- 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
- 10.1038/s41392-020-0127-9 · DOI · Paper page
- 10.1038/s41392-020-0148-4 · DOI · Paper page
- 10.4049/jimmunol.169.8.4288 · DOI · Paper page
- Wan S.X.et al.Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) [preprint](2020). https://doi.org/https://doi.org/10.1101/2020.02.10.20021832. Posted on MedRxiv. February 12 2020. · DOI · Paper page
- 10.1186/s40425-018-0343-9 · DOI · Paper page
- 10.2217/imt-2016-0020 · DOI · Paper page
- 10.3109/15412555.2013.831062 · doi:10.3109/15412555.2013.831062
- 10.1016/j.jss.2019.01.020 · DOI
- Li X., 2016, Unfractionated heparin inhibits lipopolysaccharide‐induced expression of chemokines in human endothelial cells through nuclear factor‐κB signaling pathway, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 28, 117
- Rao D., 2014, Research progress on cytokine storm induced by pathogen infection, Med. Informat., 27, 480
- 10.4049/jimmunol.165.10.5671 · DOI · Paper page
- 10.1146/annurev.biochem.68.1.729 · DOI · Paper page
- 10.1101/cshperspect.a004952 · DOI · Paper page
- 10.1111/jth.14933 · doi:10.1111/jth.14933
- 10.1152/ajplung.00199.2020 · DOI · Paper page
- 10.1172/JCI200113530 · doi:10.1172/jci200113530 · Paper page
- 10.1038/nm0897-866 · DOI · Paper page
- 10.1172/JCI200113799 · DOI
- 10.1128/JVI.01933-17 · DOI · Paper page
- Mycroft‐West D. S.et al.The 2019 coronavirus (SARS‐CoV‐2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding [preprint](2020). https://doi.org/https://doi.org/10.1101/2020.02.29.971093. Posted on BioRxiv. March 2 2020. · DOI · Paper page
- 10.1111/j.1440-1797.2008.01012.x · doi:10.1111/j.1440-1797.2008.01012.x
- 10.2174/138161207781039742 · DOI · Paper page
- 10.1038/ncomms7985 · DOI
- 10.1016/j.virol.2019.01.001 · doi:10.1016/j.virol.2019.01.001
- 10.1016/j.celrep.2017.06.041 · DOI
- 10.1371/journal.ppat.1006673 · DOI · Paper page
- 10.1016/j.ijid.2020.03.053 · DOI · Paper page
- 10.1097/01.CCM.0000059441.70680.DC · DOI
- 10.1111/jth.14768 · DOI · Paper page
- 10.1378/chest.126.4.1087 · doi:10.1378/chest.126.4.1087
- 10.1016/j.ejim.2011.10.019 · DOI
- Duarte J.C., 2015, Prognostic value of plasma D‐dimer level in adults with community‐acquired pneumonia: a prospective study, Rev. Port. Pneumol. (2006), 21, 218
Cited by
COVID-19 length of hospital stay: a systematic review and data synthesis
Rees, E. M., Nightingale, E. S., Jafari, Y., Waterlow, N. R., Clifford, S., B. Pearson, C. A., Group, C. W., Jombart, T., Procter, S. R., & Knight, G. M. (2020) · BMC Medicine · doi:10.1186/s12916-020-01726-3 · Cited by 655
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Renia, L., & Remuzzi, G. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 607
An Update on Current Therapeutic Drugs Treating COVID-19
Wu, R., Wang, L., Kuo, H.-C. D., Shannar, A., Peter, R., Chou, P. J., Li, S., Hudlikar, R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 599
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
Miesbach, W., & Makris, M. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620938149 · Cited by 443
IL-6: Relevance for immunopathology of SARS-CoV-2
Gubernatorova, E. O., Gorshkova, E. A., Polinova, A. I., & Drutskaya, M. S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.009 · Cited by 343
Metadata
- Authors
- Shi, C., Wang, C., Wang, H., Yang, C., Cai, F., Zeng, F., Cheng, F., Liu, Y., Zhou, T., Deng, B., Vlodavsky, I., Li, J., & Zhang, Y.
- Venue
- Clinical and Translational Science
- Publisher
- Wiley
- Published
- 2020-10-15
- Volume
- 13
- Issue
- 6
- Pages
- 1087-1095
- ISSN
- 1752-8054 (ISSN-L)
- 1752-8062
- OpenAlex
- W3082558676
- Cited by
- 225
- References
- 6
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- Funders
- Research and Development (2017YFC0909900)
- National Natural Science Foundation of China (81603037)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.